The estimated Net Worth of Pharmaceutical Industries L... is at least 1.83 百万$ dollars as of 21 November 2017. Pharmaceutical L owns over 357,143 units of scPharmaceuticals Inc stock worth over 1,825,001$ and over the last 7 years Pharmaceutical sold SCPH stock worth over 0$.
Pharmaceutical has made over 1 trades of the scPharmaceuticals Inc stock since 2017, according to the Form 4 filled with the SEC. Most recently Pharmaceutical bought 357,143 units of SCPH stock worth 5,000,002$ on 21 November 2017.
The largest trade Pharmaceutical's ever made was buying 357,143 units of scPharmaceuticals Inc stock on 21 November 2017 worth over 5,000,002$. On average, Pharmaceutical trades about 357,143 units every 0 days since 2017. As of 21 November 2017 Pharmaceutical still owns at least 357,143 units of scPharmaceuticals Inc stock.
You can see the complete history of Pharmaceutical L stock trades at the bottom of the page.
Over the last 7 years, insiders at scPharmaceuticals Inc have traded over 5,999,254$ worth of scPharmaceuticals Inc stock and bought 6,409,552 units worth 61,370,807$ . The most active insiders traders include Capital Management, L.P.Ra ...、Jonathan Silverstein、Advisors Llc Orbi Med Capit.... On average, scPharmaceuticals Inc executives and independent directors trade stock every 112 days with the average trade being worth of 1,808,281$. The most recent stock trade was executed by Leonard D Schaeffer on 26 August 2024, trading 11,347 units of SCPH stock currently worth 29,275$.
scpharmaceuticals is a clinical-stage pharmaceutical company focused on developing and commercializing products that, through our proprietary platform, are designed to enable the subcutaneous administration of therapies previously limited to intravenous (iv) delivery—with the goal of transforming infused therapies, advancing patient care, and reducing healthcare costs.
scPharmaceuticals Inc executives and other stock owners filed with the SEC include: